Company Lixte Biotechnology Holdings, Inc.
Equities
LIXT
US5393193017
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.76 USD | -12.10% | -14.29% | +17.45% |
04-23 | Lixte Biotechnology Files Up to $50 Million Mixed Shelf | MT |
03-27 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
Business Summary
Number of employees: 4
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 22-06-16 | |
Director of Finance/CFO | 72 | 20-08-11 | |
Eric Forman
COO | Chief Operating Officer | 44 | 12-12-31 |
James Miser
CTO | Chief Tech/Sci/R&D Officer | 77 | 20-07-31 |
Stephen Forman
BRD | Director/Board Member | 76 | 16-05-12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
René Bernards
BRD | Director/Board Member | 72 | 22-06-14 |
Chief Executive Officer | 52 | 22-06-16 | |
Yun Yen
BRD | Director/Board Member | 70 | 18-08-03 |
Stephen Forman
BRD | Director/Board Member | 76 | 16-05-12 |
Regina Brown
BRD | Director/Board Member | 61 | 21-05-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,249,290 | 1,788,596 ( 79.52 %) | 0 | 68.81 % |
Stock B | 0 | 350,000 | 0 | 0 |
Company contact information
Lixte Biotechnology Holdings, Inc.
680 East Colorado Boulevard Suite 180
91101, Pasadena
+631 830 7092
http://www.lixte.comSector
1st Jan change | Capi. | |
---|---|---|
+17.45% | 6.21M | |
+0.17% | 42.19B | |
+10.92% | 42.24B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B |
- Stock Market
- Equities
- LIXT Stock
- Company Lixte Biotechnology Holdings, Inc.